The Role of Pharmaceutical Industry Development in the Implementation of the National Security Strategy of the Russian Federation

With the onset of the new century, a shift in emphasis from maintaining military power to the need to regulate areas that have become new non-military threats to state security has gradually occurred. Demographic shifts, economic crises, epidemiological transitions, and the disproportionate access to medical care pose serious challenges to healthcare systems in leading world powers, especially in terms of drug provision. The development of pharmaceutical production is an important component of the socio-economic well-being and defense capabilities of the state, ensuring the economic and physical accessibility of medicines. The authors reviewed the state policy in the field of pharmaceutical industry development. They also analyzed the measures aimed at creating innovative potential in the field of developing new drugs and ensuring localization of the production of foreign drugs in the country. The article analyzes the effectiveness of individual measures that create incentives and preferences for the domestic pharmaceutical industry in the context of ensuring the implementation of the national security strategy of the state. © 2021, Springer Nature Switzerland AG.

Авторы
Abashidze A.K. 1 , Malichenko V.S. 2 , Putilo N.V.2
Сборник материалов конференции
Издательство
Springer Science and Business Media Deutschland GmbH
Язык
Английский
Страницы
726-732
Статус
Опубликовано
Том
280
Год
2021
Организации
  • 1 Department of International Law, RUDN University, Moscow, Russian Federation
  • 2 The Institute of Legislation and Comparative Law under the Government of the Russian Federation, Moscow, Russian Federation
Ключевые слова
Access to medicine; National security; Pharmaceutical industry; Production localization
Дата создания
16.12.2021
Дата изменения
26.01.2024
Постоянная ссылка
https://repository.rudn.ru/ru/records/article/record/76251/
Поделиться

Другие записи